Patent details

Basic Information

Publication number:

EP3078743

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP161675343

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

French Title of Invention:

ANTIDOTES POUR INHIBITEURS DU FACTEUR XA ET PROCEDES D'UTILISATION ASSOCIES

German Title of Invention:

GEGENMITTEL FÜR FAKTOR-XA-HEMMER UND VERFAHREN ZUR VERWENDUNG DAVON

SPC Number:

LUC00190

Dates

Filing date:

26/09/2008

Grant date:

24/06/2020

EP Publication Date:

12/10/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/06/2020

EP B1 Publication Date:

24/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

26/09/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/02/2021

 

 

Name:

Alexion Pharmaceuticals, Inc.

Address:

121 Seaport Boulevard, Boston, MA 02210, United States (US)

History of Owners

From:

10/12/2020

To:

05/02/2021

Name:

Alexion Pharmaceuticals, Inc.

Address:

121 Seaport Boulevard, Boston, MA 02210, United States (US)

From:

10/12/2020

To:

10/12/2020

Name:

Portola Pharmaceuticals, LLC

Address:

270 East Grand Avenue Suite 22, CA 94080, South San Francisco, California, United States (US)

From:

17/06/2020

To:

10/12/2020

Name:

Portola Pharmaceuticals, Inc.

Address:

270 East Grand Avenue Suite 22, South San Francisco California 94080, United States (US)

Agent

Name:

STOLMÁR & PARTNER

From:

07/07/2020

Address:

BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)

To:

Inventor

1

Name:

SINHA, Uma

Address:

United States (US)

2

Name:

LU, Genmin

Address:

United States (US)

3

Name:

PHILLIPS, David R.

Address:

United States (US)

4

Name:

ANDRE, Patrick

Address:

United States (US)

Priority

1

Priority Number:

976343 P

Priority Date:

28/09/2007

Priority Country:

United States (US)

2

Priority Number:

90574 P

Priority Date:

20/08/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/48; A61P 7/04; C12N 9/64;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2021/01

Publication date:

05/01/2021

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2021/01

Publication date:

05/01/2021

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202026

Publication date:

24/06/2020

Description:

Grant (B1)

2

Issue number:

202110

Publication date:

10/03/2021

Description:

Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20200000387A

Date Registered:

10/12/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

changement de forme légale

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Portola Pharmaceuticals, LLC

Address:

270 East Grand Avenue Suite 22, CA 94080, South San Francisco, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000388A

Date Registered:

10/12/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Alexion Pharmaceuticals, Inc.

Address:

121 Seaport Boulevard, Boston, MA 02210, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/09/2026

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

20/08/2025

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
10/12/2020	Request For Change	103
11/12/2020	Outgoing Correspondence	1
07/07/2020	Power Of Attorney	2
07/07/2020	Outgoing Correspondence	1
10/12/2020	Request For Change	4
11/12/2020	Outgoing Correspondence	1